Sign in

CIK 0001640266 · Accelerated filer<br>Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-21 Jorgensen Nathan D. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +103,000 103,000
2025-02-20 Carter Todd Alfred Chief Scientific Officer Sale −3,305 $4.26 $14K 77,718
2025-02-20 Sandrock Alfred President and CEO Sale −11,702 $4.24 $50K 296,816
2025-02-20 Swartz Robin COO & CBO Sale −3,894 $4.25 $17K 98,397
2025-02-11 Carter Todd Alfred Chief Scientific Officer Sale −5,413 $4.45 $24K 81,023
2025-02-11 Swartz Robin COO & CBO Sale −6,950 $4.45 $31K 102,291
2025-02-11 Sandrock Alfred President & CEO Sale −16,644 $4.45 $74K 308,518
2025-02-11 Fahey Sandell Jacquelyn Chief Legal Officer Sale −4,358 $4.45 $19K 81,643
2025-01-14 Swartz Robin COO & CBO Sale −3,087 $5.09 $16K 109,241
2025-01-14 Carter Todd Alfred Chief Scientific Officer Sale −1,191 $5.13 $6K 86,436
2024-12-23 Swartz Robin COO&CBO Sale −6,500 $5.65 $37K 112,328
2024-10-02 Fahey Sandell Jacquelyn Chief Legal Officer Sale −5,999 $5.82 $35K 86,001
2024-10-01 Jorgensen Nathan D. Chief Financial Officer Grant or award +80,000 80,000
2024-07-08 Jorgensen Nathan D. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2024-06-05 Vitale Nancy Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-05 SCANGOS GEORGE A Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-05 PIERCE GLENN Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-05 Onyia Jude Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-05 MACKEY CATHERINE J Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-05 Hyman Steven Director Grant or award · Stock Option (Right to Buy) +24,000 24,000

Page 4 of 7 · 130 trades